(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 20 20  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  0  0  0  0  0
    4.7925   -1.8140    3.2783 C   0  0  0  0  0  0
    3.4548   -2.0560    3.1332 N   0  0  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  3  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  5  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    3.8888    0.5590    1.4883 H   0  0  0  0  0  0
    2.7972   -2.8517    3.5133 H   0  0  0  0  0  0
    5.4656   -2.3478    3.7902 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.8887   -1.4024    0.7256 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  5  6  1  0  0  0
  6  7  2  0  0  0
  6 10  1  0  0  0
  7 15  1  0  0  0
  7  8  1  0  0  0
  8  9  2  0  0  0
  9 10  1  0  0  0
  9 17  1  0  0  0
 10 16  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
 11 20  1  0  0  0
M  CHG  2  11   1  12  -1
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_lp_tautomer_probability>
0.499999999999999

> <r_epik_Ionization_Penalty>
  0.0581

> <r_epik_Ionization_Penalty_Charging>
  0.0581

> <r_epik_Ionization_Penalty_Neutral>
  0.0000

> <r_epik_State_Penalty>
  0.4288

> <i_epik_Tot_Q>
0

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 20 20  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  0  0  0  0  0
    4.7929   -1.8151    3.2767 C   0  0  0  0  0  0
    3.4550   -2.0567    3.1322 N   0  0  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  3  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  5  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    4.0630    0.6508    1.4664 H   0  0  0  0  0  0
    6.1142   -0.1919    2.4952 H   0  0  0  0  0  0
    5.4534   -2.4496    3.8518 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.8887   -1.4024    0.7256 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5  6  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  6 10  1  0  0  0
  6  7  2  0  0  0
  7  8  1  0  0  0
  7 15  1  0  0  0
  8  9  1  0  0  0
  8 16  1  0  0  0
  9 10  2  0  0  0
  9 17  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
 11 20  1  0  0  0
M  CHG  2  11   1  12  -1
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_lp_tautomer_probability>
0.499999999999999

> <r_epik_Ionization_Penalty>
  0.0731

> <r_epik_Ionization_Penalty_Charging>
  0.0731

> <r_epik_Ionization_Penalty_Neutral>
  0.0000

> <r_epik_State_Penalty>
  0.5727

> <i_epik_Tot_Q>
0

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 19 19  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  0  0  0  0  0
    4.7925   -1.8140    3.2783 C   0  0  0  0  0  0
    3.4548   -2.0560    3.1332 N   0  0  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  0  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  5  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    3.8888    0.5590    1.4883 H   0  0  0  0  0  0
    2.7972   -2.8517    3.5133 H   0  0  0  0  0  0
    5.4656   -2.3478    3.7902 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  5  6  1  0  0  0
  6  7  2  0  0  0
  6 10  1  0  0  0
  7 15  1  0  0  0
  7  8  1  0  0  0
  8  9  2  0  0  0
  9 10  1  0  0  0
  9 17  1  0  0  0
 10 16  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
M  CHG  1  12  -1
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_lp_tautomer_probability>
0.499999999999999

> <r_epik_Ionization_Penalty>
  2.1717

> <r_epik_Ionization_Penalty_Charging>
  0.3050

> <r_epik_Ionization_Penalty_Neutral>
  1.8667

> <r_epik_State_Penalty>
  1.8293

> <i_epik_Tot_Q>
-1

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 21 21  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  3  0  0  0  0
    4.7925   -1.8140    3.2783 C   0  0  0  0  0  0
    3.4548   -2.0560    3.1332 N   0  0  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  3  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  5  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    3.8888    0.5590    1.4883 H   0  0  0  0  0  0
    2.7972   -2.8517    3.5133 H   0  0  0  0  0  0
    5.4656   -2.3478    3.7902 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.8887   -1.4024    0.7256 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
    6.2167   -0.4086    2.6616 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  5  6  1  0  0  0
  6  7  2  0  0  0
  6 10  1  0  0  0
  7 15  1  0  0  0
  7  8  1  0  0  0
  8  9  2  0  0  0
  8 21  1  0  0  0
  9 10  1  0  0  0
  9 17  1  0  0  0
 10 16  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
 11 20  1  0  0  0
M  CHG  3   8   1  11   1  12  -1
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_lp_tautomer_probability>
1

> <r_epik_Ionization_Penalty>
  3.5375

> <r_epik_Ionization_Penalty_Charging>
  0.0566

> <r_epik_Ionization_Penalty_Neutral>
  3.4809

> <r_epik_State_Penalty>
  1.9736

> <i_epik_Tot_Q>
1

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 20 20  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  0  0  0  0  0
    4.7929   -1.8151    3.2767 C   0  0  0  0  0  0
    3.4550   -2.0567    3.1322 N   0  3  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  0  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  5  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    4.0630    0.6508    1.4664 H   0  0  0  0  0  0
    6.1142   -0.1919    2.4952 H   0  0  0  0  0  0
    5.4534   -2.4496    3.8518 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
    2.7975   -2.8525    3.5121 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5  6  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  6 10  1  0  0  0
  6  7  2  0  0  0
  7  8  1  0  0  0
  7 15  1  0  0  0
  8  9  1  0  0  0
  8 16  1  0  0  0
  9 10  2  0  0  0
  9 17  1  0  0  0
 10 20  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
M  CHG  2  10   1  12  -1
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_epik_Ionization_Penalty>
  2.0892

> <r_epik_Ionization_Penalty_Charging>
  0.0001

> <r_epik_Ionization_Penalty_Neutral>
  2.0891

> <r_epik_State_Penalty>
  2.1157

> <i_epik_Tot_Q>
0

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 19 19  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  0  0  0  0  0
    4.7929   -1.8151    3.2767 C   0  0  0  0  0  0
    3.4550   -2.0567    3.1322 N   0  0  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  0  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  5  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    4.0630    0.6508    1.4664 H   0  0  0  0  0  0
    6.1142   -0.1919    2.4952 H   0  0  0  0  0  0
    5.4534   -2.4496    3.8518 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5  6  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  6 10  1  0  0  0
  6  7  2  0  0  0
  7  8  1  0  0  0
  7 15  1  0  0  0
  8  9  1  0  0  0
  8 16  1  0  0  0
  9 10  2  0  0  0
  9 17  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
M  CHG  1  12  -1
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_lp_tautomer_probability>
0.499999999999999

> <r_epik_Ionization_Penalty>
  2.5670

> <r_epik_Ionization_Penalty_Charging>
  0.9616

> <r_epik_Ionization_Penalty_Neutral>
  1.6055

> <r_epik_State_Penalty>
  2.1824

> <i_epik_Tot_Q>
-1

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 20 20  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  0  0  0  0  0
    4.7925   -1.8140    3.2783 C   0  0  0  0  0  0
    3.4548   -2.0560    3.1332 N   0  0  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  0  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  0  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    3.8888    0.5590    1.4883 H   0  0  0  0  0  0
    2.7972   -2.8517    3.5133 H   0  0  0  0  0  0
    5.4656   -2.3478    3.7902 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
    3.1596   -3.3422    0.4587 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  5  6  1  0  0  0
  6  7  2  0  0  0
  6 10  1  0  0  0
  7 15  1  0  0  0
  7  8  1  0  0  0
  8  9  2  0  0  0
  9 10  1  0  0  0
  9 17  1  0  0  0
 10 16  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
 12 20  1  0  0  0
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_epik_Ionization_Penalty>
  5.1265

> <r_epik_Ionization_Penalty_Charging>
  0.2458

> <r_epik_Ionization_Penalty_Neutral>
  4.8808

> <r_epik_State_Penalty>
  6.5474

> <i_epik_Tot_Q>
0

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 20 20  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  0  0  0  0  0
    4.7929   -1.8151    3.2767 C   0  0  0  0  0  0
    3.4550   -2.0567    3.1322 N   0  0  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  0  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  0  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    4.0630    0.6508    1.4664 H   0  0  0  0  0  0
    6.1142   -0.1919    2.4952 H   0  0  0  0  0  0
    5.4534   -2.4496    3.8518 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
    3.1596   -3.3422    0.4587 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5  6  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  6 10  1  0  0  0
  6  7  2  0  0  0
  7  8  1  0  0  0
  7 15  1  0  0  0
  8  9  1  0  0  0
  8 16  1  0  0  0
  9 10  2  0  0  0
  9 17  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
 12 20  1  0  0  0
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_epik_Ionization_Penalty>
  5.8299

> <r_epik_Ionization_Penalty_Charging>
  0.8156

> <r_epik_Ionization_Penalty_Neutral>
  5.0143

> <r_epik_State_Penalty>
  7.0699

> <i_epik_Tot_Q>
0

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 21 21  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  0  0  0  0  0
    4.7929   -1.8151    3.2767 C   0  0  0  0  0  0
    3.4550   -2.0567    3.1322 N   0  3  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  0  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  0  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    4.0630    0.6508    1.4664 H   0  0  0  0  0  0
    6.1142   -0.1919    2.4952 H   0  0  0  0  0  0
    5.4534   -2.4496    3.8518 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
    3.1596   -3.3422    0.4587 H   0  0  0  0  0  0
    2.7975   -2.8525    3.5121 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5  6  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  6 10  1  0  0  0
  6  7  2  0  0  0
  7  8  1  0  0  0
  7 15  1  0  0  0
  8  9  1  0  0  0
  8 16  1  0  0  0
  9 10  2  0  0  0
  9 17  1  0  0  0
 10 21  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
 12 20  1  0  0  0
M  CHG  1  10   1
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_epik_Ionization_Penalty>
  5.9248

> <r_epik_Ionization_Penalty_Charging>
  0.0000

> <r_epik_Ionization_Penalty_Neutral>
  5.9248

> <r_epik_State_Penalty>
  7.1111

> <i_epik_Tot_Q>
1

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 19 19  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  0  0  0  0  0
    4.7925   -1.8140    3.2783 C   0  0  0  0  0  0
    3.4548   -2.0560    3.1332 N   0  5  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  3  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  5  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    3.8888    0.5590    1.4883 H   0  0  0  0  0  0
    5.4656   -2.3478    3.7902 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.8887   -1.4024    0.7256 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  5  6  1  0  0  0
  6  7  2  0  0  0
  6 10  1  0  0  0
  7 15  1  0  0  0
  7  8  1  0  0  0
  8  9  2  0  0  0
  9 10  1  0  0  0
  9 16  1  0  0  0
 11 17  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
M  CHG  3  10  -1  11   1  12  -1
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_epik_Ionization_Penalty>
 14.7812

> <r_epik_Ionization_Penalty_Charging>
  7.5758

> <r_epik_Ionization_Penalty_Neutral>
  7.2055

> <r_epik_State_Penalty>
  8.7463

> <i_epik_Tot_Q>
-1

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 21 21  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  0  0  0  0  0
    4.7925   -1.8140    3.2783 C   0  0  0  0  0  0
    3.4548   -2.0560    3.1332 N   0  0  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  3  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  0  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    3.8888    0.5590    1.4883 H   0  0  0  0  0  0
    2.7972   -2.8517    3.5133 H   0  0  0  0  0  0
    5.4656   -2.3478    3.7902 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.8887   -1.4024    0.7256 H   0  0  0  0  0  0
    3.1596   -3.3422    0.4587 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  5  6  1  0  0  0
  6  7  2  0  0  0
  6 10  1  0  0  0
  7 15  1  0  0  0
  7  8  1  0  0  0
  8  9  2  0  0  0
  9 10  1  0  0  0
  9 17  1  0  0  0
 10 16  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
 11 21  1  0  0  0
 12 20  1  0  0  0
M  CHG  1  11   1
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_epik_Ionization_Penalty>
 10.1091

> <r_epik_Ionization_Penalty_Charging>
  2.7075

> <r_epik_Ionization_Penalty_Neutral>
  7.4017

> <r_epik_State_Penalty>
  8.7818

> <i_epik_Tot_Q>
1

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 21 21  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  0  0  0  0  0
    4.7929   -1.8151    3.2767 C   0  0  0  0  0  0
    3.4550   -2.0567    3.1322 N   0  0  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  3  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  0  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    4.0630    0.6508    1.4664 H   0  0  0  0  0  0
    6.1142   -0.1919    2.4952 H   0  0  0  0  0  0
    5.4534   -2.4496    3.8518 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.8887   -1.4024    0.7256 H   0  0  0  0  0  0
    3.1596   -3.3422    0.4587 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5  6  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  6 10  1  0  0  0
  6  7  2  0  0  0
  7  8  1  0  0  0
  7 15  1  0  0  0
  8  9  1  0  0  0
  8 16  1  0  0  0
  9 10  2  0  0  0
  9 17  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
 11 21  1  0  0  0
 12 20  1  0  0  0
M  CHG  1  11   1
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_epik_Ionization_Penalty>
 10.4195

> <r_epik_Ionization_Penalty_Charging>
  2.8825

> <r_epik_Ionization_Penalty_Neutral>
  7.5370

> <r_epik_State_Penalty>
  8.9455

> <i_epik_Tot_Q>
1

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 22 22  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  0  0  0  0  0
    4.7929   -1.8151    3.2767 C   0  0  0  0  0  0
    3.4550   -2.0567    3.1322 N   0  3  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  3  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  0  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    4.0630    0.6508    1.4664 H   0  0  0  0  0  0
    6.1142   -0.1919    2.4952 H   0  0  0  0  0  0
    5.4534   -2.4496    3.8518 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.8887   -1.4024    0.7256 H   0  0  0  0  0  0
    3.1596   -3.3422    0.4587 H   0  0  0  0  0  0
    2.7975   -2.8525    3.5121 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5  6  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  6 10  1  0  0  0
  6  7  2  0  0  0
  7  8  1  0  0  0
  7 15  1  0  0  0
  8  9  1  0  0  0
  8 16  1  0  0  0
  9 10  2  0  0  0
  9 17  1  0  0  0
 10 21  1  0  0  0
 11 18  1  0  0  0
 11 19  1  0  0  0
 11 22  1  0  0  0
 12 20  1  0  0  0
M  CHG  2  10   1  11   1
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_lp_tautomer_probability>
1

> <r_epik_Ionization_Penalty>
 15.1428

> <r_epik_Ionization_Penalty_Charging>
  3.0101

> <r_epik_Ionization_Penalty_Neutral>
 12.1326

> <r_epik_State_Penalty>
 10.7338

> <i_epik_Tot_Q>
2

$$$$
(2~{S})-2-amino-3-(1~{H}-imidazol-4-yl)propanoic acid
                    3D
 Structure written by MMmdl.
 18 18  0  0  1  0            999 V2000
    0.0386   -3.7692    1.2233 O   0  0  0  0  0  0
    1.0816   -3.2076    0.9049 C   0  0  0  0  0  0
    1.1716   -1.7099    0.6517 C   0  0  2  0  0  0
    1.9456   -1.5041   -0.1024 H   0  0  0  0  0  0
    1.4847   -0.9748    1.9614 C   0  0  0  0  0  0
    2.9408   -1.0603    2.3513 C   0  0  0  0  0  0
    4.0146   -0.2531    2.0581 C   0  0  0  0  0  0
    5.1646   -0.7286    2.6369 N   0  5  0  0  0  0
    4.7929   -1.8151    3.2767 C   0  0  0  0  0  0
    3.4550   -2.0567    3.1322 N   0  0  0  0  0  0
   -0.0404   -1.2102    0.0523 N   0  0  0  0  0  0
    2.2452   -3.8825    0.7450 O   0  5  0  0  0  0
    1.2291    0.0897    1.8545 H   0  0  0  0  0  0
    0.8934   -1.4136    2.7786 H   0  0  0  0  0  0
    4.0630    0.6508    1.4664 H   0  0  0  0  0  0
    5.4534   -2.4496    3.8518 H   0  0  0  0  0  0
    0.0543   -0.1277   -0.1184 H   0  0  0  0  0  0
   -0.2116   -1.7192   -0.9077 H   0  0  0  0  0  0
  1  2  2  0  0  0
  2  3  1  0  0  0
  2 12  1  0  0  0
  3  4  1  0  0  0
  3  5  1  0  0  0
  3 11  1  0  0  0
  5  6  1  0  0  0
  5 13  1  0  0  0
  5 14  1  0  0  0
  6 10  1  0  0  0
  6  7  2  0  0  0
  7  8  1  0  0  0
  7 15  1  0  0  0
  8  9  1  0  0  0
  9 10  2  0  0  0
  9 16  1  0  0  0
 11 17  1  0  0  0
 11 18  1  0  0  0
M  CHG  2   8  -1  12  -1
M  END
> <s_m_source_file>
/Users/andrea/Development/mcce-charges/epik_inhibitors/output/Histidine/Histidine-input.mol2

> <i_m_source_file_index>
1

> <r_epik_Ionization_Penalty>
 21.4902

> <r_epik_Ionization_Penalty_Charging>
  9.0975

> <r_epik_Ionization_Penalty_Neutral>
 12.3927

> <r_epik_State_Penalty>
 11.8212

> <i_epik_Tot_Q>
-2

$$$$
